Nigel Philip Davies1, Antony Bryan Morland. 1. Department of Biophysics, Imperial College of Science, Technology and Medicine, South Kensington, London, United Kingdom.
Abstract
PURPOSE: To measure the optical density of the crystalline lens and macular pigments in a group of patients with diabetes mellitus and compare the results with those in a group of control subjects. METHODS: Color matches were performed using a Wright tristimulus colorimeter. The reference wavelength used was 490 nm, desaturated with 650 nm. Lens optical density was measured by mixing spectral primaries of wavelengths 420, 515, and 650 nm to match the reference. Wavelengths 420 and 515 nm were chosen, because they are absorbed equally by the macular pigment. To measure macular pigment density, two color matches were performed, one foveal and one 5 degrees extrafoveal. The reference stimulus was matched by mixing spectral primaries of 460, 530, and 650 nm. The ratio of the foveal to extrafoveal color match gives the optical density of the macular pigment. Thirty-four diabetic patients and 34 control subjects performed the lens density color match, and of these, 26 diabetic patients and 30 control subjects performed the macular pigment density color matches. RESULTS: There is a significant increase in the optical density of the lens in diabetes with age in comparison to the control subjects (P < 0.001), with a duration dependence of 0.02 log units/year. The mean macular pigment density in the diabetic patients was 0.13 +/- 0.20 log units and in the control subjects 0.32 +/- 0.24 log units (P = 0.0015). Patients with grade 2 maculopathy had significantly lower pigment density than those with no maculopathy (P = 0.016). CONCLUSIONS: The ocular media of diabetic persons are abnormal, with increased lens and reduced macular pigment optical density. The relationship between reduced macular pigment levels with increasing severity of maculopathy may implicate oxidative stress as a causative factor.
PURPOSE: To measure the optical density of the crystalline lens and macular pigments in a group of patients with diabetes mellitus and compare the results with those in a group of control subjects. METHODS: Color matches were performed using a Wright tristimulus colorimeter. The reference wavelength used was 490 nm, desaturated with 650 nm. Lens optical density was measured by mixing spectral primaries of wavelengths 420, 515, and 650 nm to match the reference. Wavelengths 420 and 515 nm were chosen, because they are absorbed equally by the macular pigment. To measure macular pigment density, two color matches were performed, one foveal and one 5 degrees extrafoveal. The reference stimulus was matched by mixing spectral primaries of 460, 530, and 650 nm. The ratio of the foveal to extrafoveal color match gives the optical density of the macular pigment. Thirty-four diabeticpatients and 34 control subjects performed the lens density color match, and of these, 26 diabeticpatients and 30 control subjects performed the macular pigment density color matches. RESULTS: There is a significant increase in the optical density of the lens in diabetes with age in comparison to the control subjects (P < 0.001), with a duration dependence of 0.02 log units/year. The mean macular pigment density in the diabeticpatients was 0.13 +/- 0.20 log units and in the control subjects 0.32 +/- 0.24 log units (P = 0.0015). Patients with grade 2 maculopathy had significantly lower pigment density than those with no maculopathy (P = 0.016). CONCLUSIONS: The ocular media of diabeticpersons are abnormal, with increased lens and reduced macular pigment optical density. The relationship between reduced macular pigment levels with increasing severity of maculopathy may implicate oxidative stress as a causative factor.
Authors: R Theodore Smith; Jan P Koniarek; Jackie Chan; Takayuki Nagasaki; Janet R Sparrow; Kevin Langton Journal: Invest Ophthalmol Vis Sci Date: 2005-08 Impact factor: 4.799
Authors: X Adnan; Marwan Suheimat; Nathan Efron; Katie Edwards; Nicola Pritchard; Ankit Mathur; Edward A H Mallen; David A Atchison Journal: Biomed Opt Express Date: 2015-02-04 Impact factor: 3.732
Authors: Suzen M Moeller; Rick Voland; Gloria E Sarto; Vicki L Gobel; Sharyn L Streicher; Julie A Mares Journal: J Nutr Date: 2009-07-08 Impact factor: 4.798